SGH
AMED

Sivik Global Healthcare’s Amedisys AMED Stock Holding History

Sivik Global Healthcare’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,500
Closed -$1.69M – 40
2022
Q3 		$1.69M Buy
+17,500
New +$2.09M 0.94% 37
2022
Q2 		– Sell
-20,000
Closed -$3.45M – 40
2022
Q1 		$3.45M Buy
+20,000
New +$2.99M 1.42% 32
2020
Q4 		– Sell
-15,000
Closed -$3.55M – 39
2020
Q3 		$3.55M Sell
15,000
-10,000
-40% -$2.27M 1.53% 34
2020
Q2 		$4.96M Buy
+25,000
New +$4.66M 1.64% 27
2019
Q3 		– Sell
-20,000
Closed -$2.43M – 46
2019
Q2 		$2.43M Hold
20,000
– – 0.59% 48
2019
Q1 		$2.46M Hold
20,000
– – 0.91% 47
2018
Q4 		$2.34M Buy
+20,000
New +$2.36M 1.26% 35
2017
Q4 		– Sell
-55,000
Closed -$3.08M – 70
2017
Q3 		$3.08M Buy
55,000
+10,393
+23% +$550K 1.05% 36
2017
Q2 		$2.8M Buy
44,607
+10,000
+29% +$582K 1.03% 42
2017
Q1 		$1.77M Buy
34,607
+13,097
+61% +$625K 0.82% 43
2016
Q4 		$917K Sell
21,510
-8,490
-28% -$361K 0.44% 52
2016
Q3 		$1.42M Sell
30,000
-30,000
-50% -$1.5M 0.72% 41
2016
Q2 		$3.03M Sell
60,000
-9,821
-14% -$496K 1.51% 37
2016
Q1 		$3.38M Sell
69,821
-10,179
-13% -$393K 1.49% 30
2015
Q4 		$3.15M Buy
80,000
+200
+0.3% +$8K 1.49% 32
2015
Q3 		$3.03M Sell
79,800
-29,422
-27% -$1.24M 1.47% 26
2015
Q2 		$4.34M Buy
109,222
+4,022
+4% +$125K 1.51% 26
2015
Q1 		$2.82M Buy
105,200
+10,000
+11% +$282K 0.96% 46
2014
Q4 		$2.79M Sell
95,200
-4,800
-5% -$119K 1.13% 43
2014
Q3 		$2.02M Buy
+100,000
New +$1.93M 0.92% 52

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Sivik Global Healthcare's AMED Position: Q4 2022 in Review

Sivik Global Healthcare sold out of Amedisys (AMED) in Q4 2022, closing a stake of 17,500 shares — an estimated $1.69M sold.

Sivik Global Healthcare first reported a position in AMED in Q3 2014 and held it in 20 quarters. The position peaked at $4.96M in Q2 2020. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Sivik Global Healthcare reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Sivik Global Healthcare sold 17,500 Amedisys shares in Q4 2022, an estimated $1.69M.
  • Sivik Global Healthcare first reported a position in Amedisys in Q3 2014 and held it in 20 quarters.
  • Sivik Global Healthcare's Amedisys position peaked at $4.96M in Q2 2020.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Sivik Global Healthcare's 13F filing for Q4 2022, filed 8 Feb 2023.